logo-loader

Optiscan Imaging updates on the development of a new clinical system for oral cancer screening and surgery, ongoing clinical trials and new China distributor

Last updated: 13:05 30 Oct 2019 AEDT, First published: 10:01 30 Oct 2019 AEDT

Optiscan Imaging Limited (ASX:OIL) chief executive officer and chairman Darren Lurie provides an update on the development of Optiscan’s new applications in cancer screening and visual aid in cancer surgery.

Optiscan’s technology is used to enhance screening for potential cancer and a number of key trials are underway or expected to commence shortly in US and Australian hospitals.

The CEO also updates on the appointment of a new distributor in China, following a review of its China market strategy and the adoption of a multi-distributor model.
 

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

11 hours, 30 minutes ago